Please Wait
Applying Filters...
menu
    • menu
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Elsulfavirine

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Elpida (elsulfavirine) becomes the preferred first line therapy for treatment
    Elpida (elsulfavirine) becomes the preferred first line therapy for treatment

    02 Feb 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/elpida-elsulfavirine-becomes-the-preferred-first-line-therapy-for-treatment-of-hiv-infection-in-russia-301220399.html

    PRNEWSWIRE
    02 Feb 2021
    Share Share
    Viriom Initiates Phase 2 Clinical Study of Elsulfavirine Treatment of COVID-19
    Viriom Initiates Phase 2 Clinical Study of Elsulfavirine Treatment of COVID-19

    08 Apr 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/viriom-initiates-phase-2-clinical-study-of-elsulfavirine-for-treatment-of-covid-19-301037275.html

    PRNEWSWIRE
    08 Apr 2020
    Share Share
    Viriom Launches Reproductive Toxicity Studies for Elpida
    Viriom Launches Reproductive Toxicity Studies for Elpida

    03 Dec 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/viriom-launches-reproductive-toxicity-studies-for-elpida-elsulfavirine-once-weekly-oral-formulation-300967876.html

    PR NEWSWIRE
    03 Dec 2019
    Share Share
    Viriom Initiates Phase 1 Clinical Trial of Once Monthly Injectable HIV Treatment
    Viriom Initiates Phase 1 Clinical Trial of Once Monthly Injectable HIV Treatment

    20 Dec 2018

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/viriom-initiates-phase-1-clinical-trial-of-once-monthly-injectable-hiv-treatment-300769370.html

    PR NEWSWIRE
    20 Dec 2018
    Share Share